Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk

We investigated whether serial measurements of circulating tumor DNA (ctDNA) and functional tumor volume (FTV) by magnetic resonance imaging (MRI) can be combined to improve prediction of pathologic complete response (pCR) and estimation of recurrence risk in early breast cancer patients treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Magbanua, Mark Jesus M., Li, Wen, Wolf, Denise M., Yau, Christina, Hirst, Gillian L., Swigart, Lamorna Brown, Newitt, David C., Gibbs, Jessica, Delson, Amy L., Kalashnikova, Ekaterina, Aleshin, Alexey, Zimmermann, Bernhard, Chien, A. Jo, Tripathy, Debu, Esserman, Laura, Hylton, Nola, van ‘t Veer, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994408/
https://www.ncbi.nlm.nih.gov/pubmed/33767190
http://dx.doi.org/10.1038/s41523-021-00239-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994408/
https://www.ncbi.nlm.nih.gov/pubmed/33767190
http://dx.doi.org/10.1038/s41523-021-00239-3

Ejemplares similares